Advertisement
Jazz Pharmaceuticals plc

Stay Updated with the Latest Jazz Pharmaceuticals plc JAZZ News in Real Time

Find JAZZ news now at Meyka AI. Stay informed with the latest Jazz Pharmaceuticals plc stocks updates, including price news, market analysis, and expert insights.

JAZZNASDAQ
HealthcareBiotechnology
$239.32
$1.27(0.53%)
U.S. Market opens in 16h 8m
Advertisement
ME Group (LSE: MEGP) Surges 13% After Reaffirming Full-Year Profit Outlook Despite April Slowdown 
📅 2 days ago

ME Group (LSE: MEGP) Surges 13% After Reaffirming Full-Year Profit Outlook Despite April Slowdown 

On 13 July 2026, ME Group International plc (LSE: MEGP) shares climbed about 13% after the company repeated its full-year profit guidance, even though trading slowed during April. Investors took the update as a sign that the weaker month did not reflect the company’s overall performance. Trading improved from May, while the Wash.ME laundry business…

Read more 12
AstraZeneca Shares Plunge 7.4% After Heart Drug Trial Fails—July 10
📅 5 days ago

AstraZeneca Shares Plunge 7.4% After Heart Drug Trial Fails—July 10

AstraZeneca stock fell 7.4% after Wainua heart drug trial missed primary goal. Jefferies models $2.5B sales loss. Meyka grades AZN B+, forecasts $131.71 by year-end.

Read more 12
Blue Jet Healthcare (NSE: BLUEJET) Surges 8.5% After Raising ₹800 Crore Through QIP at ₹506 Per Share
📅 5 days ago

Blue Jet Healthcare (NSE: BLUEJET) Surges 8.5% After Raising ₹800 Crore Through QIP at ₹506 Per Share

Blue Jet Healthcare shares jumped as much as 8.5% on July 10, 2026. The rally followed the company’s ₹800 crore fundraise through a Qualified Institutional Placement. Blue Jet Healthcare allotted 15,810,276 equity shares at ₹506 each, a discount to the floor price. The QIP window ran from July 6 to July 9, 2026, before the…

Read more 12
AstraZeneca (LON: AZN) Shares Plunge Up to 9% After Wainua Misses Primary Endpoint in Late-Stage Trial
📅 6 days ago

AstraZeneca (LON: AZN) Shares Plunge Up to 9% After Wainua Misses Primary Endpoint in Late-Stage Trial

AstraZeneca shares plunged as much as 9.55% on Thursday, July 9, 2026, after a major trial setback. The company’s heart drug Wainua failed to meet its primary endpoint in a Phase III study. That single announcement wiped out between £19 billion and £20 billion in market value. AstraZeneca’s market capitalization fell below £200 billion, though…

Read more 12
FTSE 100 Falls 0.49% as U.S.-Iran Tensions Escalate; AstraZeneca Slumps After Late-Stage Trial Failure
📅 6 days ago

FTSE 100 Falls 0.49% as U.S.-Iran Tensions Escalate; AstraZeneca Slumps After Late-Stage Trial Failure

The FTSE 100 traded lower on Thursday, July 9, 2026, down roughly 0.5% during the morning session. AstraZeneca shares plunged as much as 9.55%, wiping out nearly £19 billion in market value. That single stock drove almost all of London’s underperformance versus other European indices. Germany’s DAX gained 0.4%, while France’s CAC 40 rose 0.45%…

Read more 12
EasyJet Shares Surge Over 10% as £5.5 Billion Castlelake Buyout Bid Enters Final Stages 
📅 9 days ago

EasyJet Shares Surge Over 10% as £5.5 Billion Castlelake Buyout Bid Enters Final Stages 

On July 6, 2026, EasyJet shares jumped more than 10% after the British low-cost airline confirmed it had reached an agreement in principle with U.S. investment firm Castlelake on a £5.5 billion takeover proposal. The announcement lifted investor confidence and fueled expectations that one of the year’s biggest airline acquisitions could move ahead. While the…

Read more 12
European Markets: FTSE 100 Gains 0.26%, CAC 40 Climbs 0.30% as Geopolitical Risks Remain in Focus
📅 9 days ago

European Markets: FTSE 100 Gains 0.26%, CAC 40 Climbs 0.30% as Geopolitical Risks Remain in Focus

FTSE 100 edged higher on July 6 as European equities opened the week with cautious gains despite ongoing geopolitical concerns. The UK’s benchmark index rose 0.26%, while France’s CAC 40 advanced 0.30% during early trading. Germany’s DAX also traded modestly higher as investors monitored developments in the Middle East, global trade discussions, and expectations for…

Read more 12
Craneware (LON:CRW) Shares Plunge 23% to Lowest Level Since 2016 After Cutting FY Revenue Outlook
📅 12 days ago

Craneware (LON:CRW) Shares Plunge 23% to Lowest Level Since 2016 After Cutting FY Revenue Outlook

Craneware plc shares fell as much as 23% today, touching an intraday low of 988 pence. That marks the stock’s lowest level since November 28, 2016. The Edinburgh-based healthcare financial software firm issued an unscheduled trading update warning that full-year results would miss market expectations.  Craneware now guides FY26 revenue to $205 million to $208…

Read more 12
FTSE 100 Up 0.16% After UK GDP Growth Accelerates, While Pound Dips to $1.3245
📅 15 days ago

FTSE 100 Up 0.16% After UK GDP Growth Accelerates, While Pound Dips to $1.3245

The FTSE 100 moved higher on Monday as investors welcomed stronger UK economic data and looked past ongoing global uncertainty. The benchmark index gained after official figures confirmed that the UK economy expanded faster than expected during the first quarter. At the same time, the British pound weakened against the US dollar, giving support to…

Read more 12

JAZZ News FAQ